Clinical Trial: A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07814872) titled 'A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment' on Sept. 06.

Brief Summary: Many clinical trials evaluating cancer treatments require patients to undergo testing for specific molecular markers as part of eligibility screening, typically using immunohistochemistry or sequencing. Because relatively few patients may carry a required marker, trial investigators often test large numbers of patients to identify the few who may ultimately qualify for enrollment.

Pathology laboratories routinely produce hematoxylin-and-eosin (H&E) slides during canc...